# US 2022/0022736 A1 · Systems and methods for collecting and screening of pancreatic secretions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0022736 A1
- Document ID: US20220022736A1
- Status: Published application
- Kind: A1
- Application number: 17/384,101
- Filed: 2021-07-23
- Published: 2022-01-27
- Earliest claimed: 2020-07-24
- Assignees: AnX Robotica Corp.
- Applicants: AnX Robotica Corp
- Inventors: Xiaodong DUAN; Guohua XIAO; Kevin RUBEY
- Web page: https://patentgrep.com/patent/US20220022736A1

## CPC

- A61B 1/041: {Capsule endoscopes for imaging}
- A61B 1/00094: {Suction openings}
- A61B 1/00097: {Sensors}
- A61B 1/00147: {Holding or positioning arrangements}
- A61B 1/00181: {for multiple fixed viewing angles (A61B1/00193 takes precedence)}
- A61B 1/015: Control of fluid supply or evacuation
- A61B 1/05: characterised by the image sensor, e.g. camera, being in the distal end portion
- A61B 1/273: for the upper alimentary canal, e.g. oesophagoscopes or gastroscopes
- A61B 5/073: {Intestinal transmitters}
- A61B 5/14507: {specially adapted for measuring characteristics of body fluids other than blood (devices for taking samples of body liquids A61B10/0045)}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- C08F 220/48: with nitrogen-containing monomers
- C08J 5/18: Manufacture of films or sheets
- C12Q 1/37: involving peptidase or proteinase
- G01N 33/52: Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper {and including single- and multilayer analytical elements (immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72)}
- G01N 33/523: {the element being adapted for a specific analyte}
- A61B 1/00101: {the distal tip features being detachable}
- A61B 2560/063: Devices specially adapted for delivering implantable medical measuring apparatus
- A61B 2562/162: Capsule shaped sensor housings, e.g. for swallowing or implantation
- C08J 2333/20: Homopolymers or copolymers of acrylonitrile (C08J2355/02 takes precedence)
- G01N 2333/976: Trypsin; Chymotrypsin
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Disclosed here are systems and methods for collecting and/or screening of a pancreatic secretion, using a capsule endoscope comprising an imaging system and a trypsin sensor, and a tether coupled to the capsule endoscope.

## Claims

### Claim 1

A system, comprising:
a capsule endoscope comprising an imaging system and a trypsin sensor, wherein the trypsin sensor is configured to detect trypsin in a fluid that is in contact with the trypsin sensor; and
a tether comprising a flexible member comprising a lumen, wherein the flexible member is in fluidic communication with the capsule endoscope.

### Claim 2 (depends on 1)

The system of claim 1, wherein the trypsin sensor comprises a trypsin detection film.

### Claim 3 (depends on 2)

The system of claim 2, wherein the trypsin sensor is configured to detect fluid comprising a pancreatic secretion, thereby identifying the location of duodenal papilla.

### Claim 4 (depends on 3)

The system of claim 3, wherein the system is configured to withdraw a sample comprising the pancreatic secretion.

### Claim 5 (depends on 2)

The system of claim 2, wherein the trypsin detection film comprises a substrate and a dye attached to the substrate.

### Claim 6 (depends on 5)

The system of claim 5, wherein the dye is in contact with the fluid and changes color, wherein trypsin is present in the fluid.

### Claim 7 (depends on 6)

The system of claim 6, wherein the dye changes color when in contact with fluid having a trypsin concentration of at least about 300 μg/mL.

### Claim 8 (depends on 5)

The system of claim 5, wherein the dye is selected from the group consisting of bromocresol purple dye, 3′,5,5′-tetramethyl benzidine dye, triarylmethane dye, xylenol orange dye, and metal complex dye.

### Claim 9 (depends on 8)

The system of claim 8, wherein the concentration of the dye is about 0.25 to 2.5 mg/mL.

### Claim 10 (depends on 5)

The system of claim 5, wherein the substrate is a polymeric film substrate.

### Claim 11 (depends on 10)

The system of claim 10, wherein the polymeric film substrate comprises bromobutane, vinylimidazole, acrylonitrile, or any combination thereof.

### Claim 12 (depends on 11)

The system of claim 11, wherein the polymeric film substrate comprises bromobutane and vinylimidazole, wherein the molar ratio of bromobutane to vinylimidazole is from 2:1 to 1:1.

### Claim 13 (depends on 11)

The system of claim 11, wherein the polymeric film substrate comprises bromobutane and vinylimidazole, and acrylonitrile, wherein the mass of acrylonitrile is greater than or equal to the sum of the masses of bromobutane and vinylimidazole.

### Claim 14 (depends on 1)

The system of claim 1, further comprising a vacuum source arranged in fluidic communication with the lumen.

### Claim 15 (depends on 14)

The system of claim 14, wherein the vacuum source comprises a syringe or pump.

### Claim 16 (depends on 1)

The system of claim 1, wherein the tether comprises a clamp configured to engage the capsule endoscope.

### Claim 17 (depends on 16)

The system of claim 16, wherein the clamp is configured to releasably engage the capsule endoscope.

### Claim 18 (depends on 16)

The system of claim 16, wherein the clamp comprises a port configured to be in fluidic communication with the lumen and with an environment outside the clamp while the clamp is engaged with the capsule endoscope.

### Claim 19 (depends on 1)

The system of claim 1, wherein the capsule endoscope is magnetically controllable.

### Claim 20

A method, comprising:
advancing a capsule endoscope into a gastrointestinal tract of a patient, wherein the capsule endoscope comprises an imaging system and a trypsin sensor, and wherein the capsule endoscope is in fluidic communication with a tether comprising a flexible member with a lumen;
positioning the capsule endoscope at a region of interest;
detecting trypsin in a fluid that is in contact with the trypsin sensor; and
withdrawing a sample from the region of interest through the lumen.

### Claim at position 21

21-43. (canceled)
